During peritoneal dialysis (PD), the peritoneum is exposed to bioincompatible dialysis fluids, which causes progressive fibrosis and angiogenesis and, ultimately, ultrafiltration failure. In addition, repeated episodes of peritonitis or hemoperitoneum may accelerate all these processes. Fibrosis has been classically considered the main cause of peritoneal membrane functional decline. However, in parallel with fibrosis, the peritoneum also displays increases in capillary number (angiogenesis) and vasculopathy in response to PD. Nowadays, there is emerging evidence pointing to peritoneal microvasculature as the main factor responsible for increased solute transport and ultrafiltration failure. However, the pathophysiologic mechanism(s) involved in starting and maintaining peritoneal fibrosis and angiogenesis remain(s) elusive. Peritoneal stromal fibroblasts have been considered (for many years) the cell type mainly involved in structural and functional alterations of the peritoneum; whereas mesothelial cells have been considered mere victims of peritoneal injury caused by PD. Recently, ex vivo cultures of effluentderived mesothelial cells, in conjunction with immunohistochemical analysis of peritoneal biopsies from PD patients, have identified mesothelial cells as culprits, at least in part, in peritoneal membrane deterioration. This review discusses recent findings that suggest new peritoneal myofibroblastic cells may arise from local conversion of mesothelial cells by epithelial-to-mesenchymal transition during the repair responses that take place in PD. The transdifferentiated mesothelial cells may retain a permanent mesenchymal state, as long as initiating stimuli persist, and contribute to PD-induced fibrosis and angiogenesis, and hence to membrane failure. Future therapeutic interventions could be designated in order to prevent or reverse epithelial-to-mesenchymal transition of mesothelial cells, or its pernicious effects. (7) . The biochemical and morphological changes to MCs are reminiscent of those that take place during epithelial-to-mesenchymal transition (EMT) (7). Also called "transdifferentiation," EMT is a complex process that starts with disruption of intercellular junctions and loss of the apical-basolateral polarity typical of epithelial cells, the latter being transformed into fibroblastlike cells with increased migratory, invasive, and fibrogenic features (8) . Some molecular events involved in EMT have been delineated. In particular, the transcriptional repressor Snail that belongs to the zinc-finger family of transcription factors appears to be a potent inducer of EMT during embryonic development and cancer progression (9) . Snail-induced EMT is due partially to the direct repression of E-cadherin transcription (10, 11) . In addition, Snail also acts as a survival factor and as an inducer of cell movement and invasion (9) . Recent findings have suggested that new fibroblasts may arise from local conversion of MCs by EMT during peritoneal tissue repair responses induced by PD (7, 12) . A portion of these fibroblast-like MCs are released into PD fluid, allowing their study, whereas some remaining cells invade the submesothelial stroma due to their increased migratory/invasive capacity, and may contribute to PD-induced fibrosis of the peritoneum (7, 12) .
The most important factors of PD solutions responsible for peritoneal deterioration appear to be glucose and glucose degradation products, which, through the formation of advanced glycation end products (AGEs), stimulate the production of various mediators, including transforming growth factor beta (TGF-β), a potent profibrotic factor (13) (14) (15) (16) . Synthesis of TGF-β may also be stimulated by acute or chronic peritoneal infections via peritoneal leukocyte-derived factors. In this respect, TGF-β has been found to be upregulated in peritoneal inflammatory processes and its overexpression has been correlated to worse PD outcomes (17) .
It is well known that fibrosis is not a unique structural alteration of the peritoneal membrane induced by PD. In parallel, the peritoneum also shows an increase in vasculopathy and the number of capillaries (angiogenesis) (2) . There is evidence that angiogenesis and increased microvascular permeability are key determinants of increased solute transport across the peritoneal membrane and ultrafiltration failure (2) . Vascular endothelial growth factor (VEGF) is a potent proangiogenic cytokine involved in endothelial cell proliferation and vascular permeability (18) . It has been proposed that local production of VEGF during PD plays a central role in the processes leading to peritoneal angiogenesis and functional decline (19) (20) (21) (22) . Recent findings show a clear association between EMT of MCs, synthesis of VEGF, and peritoneal membrane failure (22) .
Uremic status may also affect the anatomy of the peritoneal membrane and its transport characteristics. For instance, the peritoneum of partially nephrectomized rats showed increased permeability associated with upregulation of nitric oxide synthase isoforms, VEGF, and basic fibroblast growth factor, and accumulation of AGEs (23) . Thus, it is conceivable that uremia may also affect the phenotype of MCs and contributes, in conjunction with PD-induced injury, to the progression of EMT of these cells.
There is not yet a definitive treatment for the progressive thickening and angiogenesis of peritoneal membrane associated with PD. The observation that EMT of MCs is a key process in the initiation of peritoneal fibrosis and angiogenesis opens new insights for therapeutic intervention. Such treatments may directly target the EMT process or prevent its deleterious effects, including extracellular matrix synthesis and/or VEGF production.
ISOLATION AND CULTURE OF HUMAN MCs FROM PERITONEAL EFFLUENTS AND OMENTUM
Effluent-derived MCs can be easily isolated from PD patients using a method described previously (24, 25) and modified later by our group and others (26, 27) . Briefly, nocturnal peritoneal dialysates from clinically stable patients are drained and processed immediately. Bags are hanged for 3 -4 hours in an incubator at 37°C to facilitate the accumulation of floating cells at the bottom of the bags. The supernatant is then carefully removed by vacuum with a sterile pipette, leaving approximately 200 mL of sediment. The cells are transferred to four 50-mL tubes, centrifuged at 1500 rpm for 20 minutes, and washed twice with phosphate-buffered saline (PBS). The cell pellets are suspended in 5 -7 mL of culture medium, counted in a Neubauer chamber, seeded in 25-cm 2 tissue culture flasks, and incubated at 37°C in a humidified atmosphere with 5% CO 2 . The culture medium employed is M199 (Biological Industries, Kibbutz Beit Haemek, Israel) supplemented with 20% fetal bovine serum, 100 IU/mL penicillin, 100 µg/mL streptomycin, and 2% Biogro-2 (Biological Industries), which contains insulin, transferrin, ethanolamine, and putrescine. The culture medium is replaced every 2 -3 days. Peritoneal leukocytes that might adhere to the culture plates detach after 48 hours and are then removed by subsequent washes.
Normal MCs are used as control cells and are obtained, using the method described by Stylianou et al., from omentum collected from consenting nonuremic patients undergoing elective abdominal surgery (28) . Briefly, omental specimens are collected in ice-cold PBS, washed extensively to remove the clots, and cut into pieces 2 -3 cm in diameter. These pieces are transferred to tubes containing a pre-warmed solution with 0.125% trypsin and 0.01% EDTA, and incubated for 15 minutes at 37°C with constant shaking. The preparations are centrifuged at 500g -700g for 5 minutes and the supernatants and undigested tissues are discarded. The cell pellets are washed, suspended in 5 mL M199 medium, seeded in 25-cm 2 tissue culture flasks, and incubated at 37°C in 5% CO 2 . Medium is replaced every 48 hours until the cells reach confluence.
To split the cells, confluent cultures are washed with PBS and treated with 2 -4 mL 0.125% trypsin and 0.01% EDTA for 5 -10 minutes at room temperature. Culture medium is then added to stop the trypsin-mediated digestion and the detached cells are seeded in six-well plates at a density of 2 × 10 4 cells/well and incubated as described above. Mesothelial cell cultures remain stable without any evident sign of senescence for at least two to three passages.
The purity of effluent-and omentum-derived MC cultures is determined by expression of standard mesothelial markers: E-cadherin, intercellular adhesion molecule-1 (ICAM-1), cytokeratins, cancer antigen 125 (CA125), and calretinin (7) ( Table 1) . Although some of these markers are eventually lost during EMT of the MCs, others, such as ICAM-1 and CA125, remain expressed in transdifferentiated cells. None of these markers are expressed by peritoneal fibroblasts (Table 1) . To exclude contamination by endothelial cells, the MC cultures should be negative for von Willebrand factor (7, 22) .
One of the most important advantages of using effluent-derived MC cultures from PD patients is that they may be representative of the remaining mesothelium and may reflect the structural and functional status of the peritoneal tissue. This fact allows us to use biomarkers to study morphological and functional characteristics of MCs and their clinical correlations. It can be argued that effluent MCs are not representative of the mesothelium because they might be cells committed to detach from the tissue. However, the data obtained in vivo and in vitro indicate that the MCs released into PD effluent are representative of the MC population that remains attached to the peritoneum (4, 7, 12, 22, 29) .
A possible limitation of this methodology is the limited number of MCs (normally around 25000 ± 3000) that are released into PD effluent during nocturnal exchanges. Furthermore, some patients drain a very small number of MCs, with low proliferation capacity. However, this limitation occurs in a low number of patients (<5%), usually those patients with a highly damaged peritoneum. An additional limitation is the eventual changes that MCs might undergo during the repetitive subcultures. It is thus not advisable to perform studies on these primary cells after the second or third passage.
With respect to omentum-derived MCs, an important limitation is possible contamination of the cultures with submesothelial fibroblasts and, to a lesser extent, with endothelial cells. The contamination results from prolonged incubation of the tissue with trypsin-containing solution. In our experience, trypsin treatment of the omental specimens for 15 minutes at 37°C generally provides highly pure MC cultures, without any sign of contamination. Omentum-derived MCs have a limited life span in culture, and their phenotype is only preserved up to the third or fourth passage. After that, these cells show a progressive increase in cell size, which is associated with senescence.
EPITHELIAL-TO-MESENCHYMAL TRANSITION OF MCs AND PD
We have described that confluent MC cultures from PD effluents may show three major morphologies: cobblestone-like (similar to omentum-derived MCs), transitional, and fibroblast-like MCs that remain stable for at least two to three cell passages [ Figure 1(a)-(d) ]. After analyzing more than 200 MC cultures with growth capacity from at least 96 PD patients, we determined that the frequencies of the different effluent-derived MC cultures are approximately 53% for cobblestone-like, 24% for transitional, and 17% for fibroblast-like MCs. The prevalence of non-epithelioid MC cultures (transitional or fibroblast-like) is associated with the time the patients have been on PD and with episodes of acute or recurrent peritonitis or hemoperitoneum (7) . We have also described a less frequent (<6%) cell culture with mixed morphologies [ Figure 1 unable to proliferate (30) . Although the presence of hypertrophic MCs in effluent has been considered a marker of peritoneal sclerosis by some authors (31,32), we have found that the presence of these cells is not associated with anatomical or functional peritoneal alterations (30) . Mesothelial cells from effluents show high expression of ICAM-1 and CA125 independently of their morphology, and even mixed cultures are homogeneous in their expression of these markers. In contrast, these mesothelial markers are negligible on peritoneal fibroblasts, supporting the idea that effluent transitional and fibroblast-like cells have a mesothelial origin, and indicating the lack of fibroblast contamination (7) ( Table 1) .
Analysis of cytokeratins and E-cadherin expression, which are typical epithelial markers and highly expressed in MCs, is important to determine more precisely the nature of effluent-derived cells (Table 1) . High expression of cytokeratins and E-cadherin is observed only in omentum-derived MCs, whereas effluent-derived cells show a progressive reduction in the expression of these molecules, although even fibroblast-like MCs may maintain a small population of positive cells. In mixed populations, expression of cytokeratins and E-cadherin is normally bimodal (7) . Fibroblasts are completely negative for these two markers. Vertical sections of confocal immunofluorescence microscopy of preparations stained for CD9, which is expressed at apical microvilli and intercellular contacts, show a gradual loss of apicalbasolateral polarity, already evident in cobblestone-like MCs that are half as tall as omental MC. Previous studies have characterized the cobblestone-like MCs from effluents as indistinguishable from omentum-derived MCs (27) . However, already at this early stage, a loss of apical-basolateral polarity, as well as downregulation of cytokeratins and E-cadherin, is observed ex vivo, even though cells still show an epithelioid appearance (7) .
The morphological changes and downregulation of cytokeratin and E-cadherin in effluent-derived MCs are indicative of EMT. Additional evidence that the PD-induced changes in MCs are due to EMT come from analysis of the expression of Snail in these cells. Omentum-derived MCs do not express Snail mRNA, whereas a progressive expression of this mRNA is observed in effluent MC preparations along the transdifferentiation process (7) .
The MCs that have undergone EMT acquire higher migratory and invasive capacities that allow them to invade the submesothelial stroma (7, 12, 33) . In this context, immunohistochemical analysis of peritoneal biopsies from PD patients reveals the presence of fibroblast-like cells embedded in the fibrotic stroma, expressing mesothelial markers such as cytokeratins, 
ICAM-I = intercellular adhesion molecule-1; CA125 = cancer antigen 125; VEGF = vascular endothelial growth factor; α-SMA= α-smooth muscle actin; CTGF = connective tissue growth factor; TGF-β = transforming growth factor beta; ND = not determined. peritoneal myofibroblastic cells may arise from local conversion of MCs by EMT during the repair responses that take place in PD (7, 12) . Recently, the myofibroblastic conversion of MCs was confirmed in vivo by injection of an adenovirus vector that transferred active TGF-β1 in rat peritoneum (29) . 
ROLE OF EMT OF MCs IN PERITONEAL FIBROSIS AND ANGIOGENESIS
Peritoneal fibrosis consists of the accumulation of extracellular matrix proteins (collagen I, III, V, VI, fibronectin, tenascin) in the interstitium, with an increased number of fibroblasts, some of them harboring myofibroblastic features. The presence of a high population of fibroblasts is normally representative of tissues fibrosis, but their origin is debated. The classic concept suggests that fibroblasts are simply residual embryonic mesenchymal cells that remained in the different tissue after organogenesis. However, the current view argues that fibroblasts may arise from local conversion of epithelial cells by EMT, or from CD34+ cells (fibrocytes) of the bloodstream after being recruited from bone marrow (35, 36) . In the case of renal fibrosis models, it has been shown that 36% of new fibroblasts derive from EMT, 15% from bone marrow, and the rest from local proliferation of resident fibroblasts (35) . In PD-related fibrosis, the expression of mesothelial markers has been demonstrated in stromal spindle-like cells, suggesting that they stemmed from local conversion of MCs (7, 12) , but the contribution of cells recruited from bone marrow to the submesothelial fibroblast population remains to be established.
TGF-β is considered the master molecule in the genesis of peritoneal fibrosis because it plays a central role in triggering and perpetuating many wound healing processes (37) . The relevance of TGF-β in peritoneal fibrosis has been demonstrated in an in vivo rat model in which the TGF-β gene was transduced into the peritoneal cavity with an adenovirus vector, reproducing the structural and functional alterations observed in PD patients (13, 29) . On the other hand, TGF-β is one of the most important triggering factors of EMT of different epithelial cells, including MCs (4, 7, 34) . TGF-β-induced mesenchymal conversion of MCs results in upregulated expression of extracellular matrix proteins in these cells (34) . In addition, effluent-derived MCs with a fibroblastlike phenotype produce greater amounts of fibronectin and collagen I than epithelioid MCs (22) . Thus, it can be proposed that MCs that have undergone EMT may play an active role in the initiation of fibrosis and subsequent decline in peritoneal function.
In addition to fibrosis, an increased number of capillaries is also related to peritoneal membrane failure, which is characterized by increased transport of glucose and small solutes, leading to loss of ultrafiltration (2) (3) (4) . Local production of VEGF during PD appears to play a central role in processes leading to peritoneal angiogenesis and functional decline (19) (20) (21) (22) . However, the main source of VEGF in PD patients, as well as the mechanisms implicated in VEGF upregulation during PD, remains unclear. A number of studies have shown that MCs from omentum have the capacity to produce VEGF in vitro in response to a variety of stimuli, such as glucose degradation products, AGEs, and TGF-β (22, (38) (39) (40) . Furthermore, it has been reported that effluent-derived MCs spontaneously produce different levels of VEGF ex vivo, but the reason for these different VEGF production abilities were not established (41) . Recently, we found that the mechanism underlying VEGF upregulation in MCs is the mesenchymal conversion of these cells, which is induced by PD itself and by episodes of peritonitis or hemoperitoneum. In addition, we demonstrated that the peritoneal transport rate correlates with VEGF produced ex vivo by effluentderived MCs and with their phenotype (22) .
CONCLUDING REMARKS
Recent findings suggest that new fibroblast-like cells arise in the peritoneum from local conversion of MCs by EMT during the repair responses that take place in longterm PD. These transdifferentiated MCs may invade the submesothelial tissue and contribute to peritoneal fibrosis and angiogenesis, which ultimately lead to peritoneal membrane failure (Figure 3) . Thus, EMT may emerge as a . Some of the transdifferentiated MC are released to the PD effluent and the remaining cells invade the submesothelial stroma, where they participate in the fibrotic and angiogenic processes that ultimately lead to peritoneal ultrafiltration (UF) failure. AGEs = advanced glycation end products; GDPs = glucose degradation products; TGF-β = transforming growth factor beta; FGF = fibroblast growth factor; VEGF = vascular endothelial growth factor.
